Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Regulatory News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

10 Jan 2019 14:05

RNS Number : 7878M
Redx Pharma plc
10 January 2019
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMSFIFLSFUSESF
Date   Source Headline
1st Nov 20217:00 amRNSAppointment of Non-Executive Chair
11th Oct 20217:00 amRNSR&D Day and New Clinical Data for ROCK2 Inhibitor
5th Oct 20217:00 amRNSRedx to host Virtual R&D Day on 11 October 2021
27th Sep 20218:00 amRNSExercise of Options and Total Voting Rights
20th Sep 20214:59 pmRNSRedx Presents Encouraging Phase 1 Data for RXC004
17th Sep 202111:06 amRNSSecond Price Monitoring Extn
17th Sep 202111:00 amRNSPrice Monitoring Extension
16th Sep 202112:16 pmRNSPrice Monitoring Extension
16th Sep 202112:15 pmRNSSecond Price Monitoring Extn
16th Sep 202112:12 pmRNSSecond Price Monitoring Extn
16th Sep 202112:08 pmRNSPrice Monitoring Extension
14th Sep 20212:05 pmRNSSecond Price Monitoring Extn
14th Sep 20212:00 pmRNSPrice Monitoring Extension
14th Sep 202111:05 amRNSSecond Price Monitoring Extn
14th Sep 202111:00 amRNSPrice Monitoring Extension
13th Sep 20217:00 amRNSRXC004 Phase 1 data to be presented at ESMO 2021
2nd Sep 20217:00 amRNSMilestone Payment from Jazz Pharmaceuticals
27th Jul 20217:00 amRNSRedx Announces Phase 2 Dose Selection of RXC004
8th Jul 20211:43 pmRNSExercise of Options and Total Voting Rights
1st Jul 202111:08 amRNSNew Grant of Options and Director/PDMR Dealing
17th Jun 20217:00 amRNSRedx Receives Milestone Payment for RXC006
7th Jun 20217:00 amRNSInterim results for the six months ended 31 March
4th Jun 20217:00 amRNSChange of Auditor
3rd Jun 20217:00 amRNSFirst Subject Dosed in Phase 1 Study with RXC007
1st Jun 20217:00 amRNSDirectorate Change
24th May 20217:00 amRNSNotice of Interim Results
19th May 20217:00 amRNSAppointment of Non-Executive Director
5th May 20217:00 amRNSAppointment of Peter Collum as CFO
30th Apr 20219:00 amRNSConfirmation of post offer intention statements
28th Apr 20217:00 amRNSDosing of first patients with RXC004 and Anti-PD1
29th Mar 20219:00 amRNSRedx to present at AACR
15th Mar 20217:00 amRNSAppointment of Joint Broker
2nd Mar 202112:38 pmRNSResult of AGM and Directorate change
1st Mar 20219:57 amRNSNew Grant of Options
25th Feb 20217:00 amRNSPresentation at Cowen Healthcare Conference
5th Feb 20215:23 pmRNSNotice of AGM
27th Jan 20217:00 amRNSFinal Results for the Year Ended 30 September 2020
14th Jan 20217:00 amRNSNotice of Preliminary Results
29th Dec 20207:00 amRNSTR-1: Notification of major holdings
23rd Dec 20209:00 amRNSShare Purchases by Directors
22nd Dec 20205:13 pmRNSTR-1: Notification of major holdings
22nd Dec 20208:30 amRNSAdmission of Placing
21st Dec 202012:26 pmRNSResults of Open Offer and General Meeting
2nd Dec 20207:10 amRNSNew Grant of Options
2nd Dec 20207:00 amRNSPlacing and Open Offer Announcement
27th Oct 20207:00 amRNSAppointment of Chief Medical Officer
9th Sep 20207:00 amRNSResearch collaboration with Jazz Pharmaceuticals
3rd Sep 20203:00 pmRNSTR-1: Notification of major holdings
17th Aug 20202:05 pmRNSSecond Price Monitoring Extn
17th Aug 20202:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.